Project Details
Description
Phase 2 clinical pharmacology study in nmDMD patients to assess dystrophin levels in patients with nmDMD who have been treated with ataluren
| Status | Active |
|---|---|
| Effective start/end date | 12/1/18 → 11/30/23 |
Funding
- PTC THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.